Considering that blockade of MLK3 could inhibit both JNK and ERK, combined inhibition of PI3Kβ and MLK3 may display stronger synergistic anti-glioblastoma effects, compared with dual inhibition of PI3Kβ and JNK, or PI3Kβ and ERK. This evidence concerns the gene MAP3K11 and glioblastoma.